HOTAIRM1 and central nervous system cancer: Moreover, as exhibited in Table 2, the high expression of HOTAIRM1 was correlated with the tumor diameter (P = 0.0073), tumor recurrence (P = 0.0321) and WHO grade (P = 0.0094) in glioma patients.